London based producer of health, hygiene and nutrition products Reckitt Benckiser Group (LON: RKT) has released its results for the second quarter in which it registered declined sales in the quarter further warning of costs will hit margins.
For the second quarter ended June 30, sales in the health business of the company which consists of Mucinex cough syrup and Strepsils lozenges dropped by 5.6% while its hygiene businesses which includes notable brands like Harpic, Airwick and Veet among others posted a 7.8% increase in sales.
Some of the popular brands produced by the company include Finish, Veet, Airwick and Harpic, these four alone make around 70% of the total sales made by the company. Reckitt said the products registered sales growth in the quarter but far much less that the growth what they registered at a similar quarter last year.
The company says the slight sales increase in some products such as Lysol disinfectants can be attributed to easing of lockdown measures in Britain.
The company’s CEO, Laxman Narasimhan, said sales for its cold flu products also registered a slight increase in the quarter.
